Natural killer cell deficiency should be considered in patients susceptible to herpes virus or papillomavirus with persistently decreased NK cell function.
Updates on therapies for relapsing-remitting MS from ACTRIMS 2025 include the effects of B-cell-depleting agents in minority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback